Earnings · China A-shares
Jiangsu Jibeier Pharmaceutical Co. Ltd. Class A (688566) earnings
Jiangsu Jibeier Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-29: net profit -10.66% year on year, +14.15% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -2.63% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -10.66%
- Excl. one-offs YoY
- +14.15%
- Net profit QoQ
- +33.95%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +0.00% | — |
| 3 days | -2.63% | — |
| 7 days | -2.56% | — |
| 14 days | -7.25% | — |
Report history
Over the last 8 reports, net profit grew year on year in 4 of them. The stock rose in the 3 trading days after 2 of 6 reports (average +0.26%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥175.92M | -10.66% | +14.15% | +9.98% | 0.88 | 7.00% | -2.63% | — | — |
| 2026 interim report | 2026-08-28 | ¥99.24M | -33.54% | -6.92% | +7.61% | 0.50 | 4.00% | +0.39% | +5.38% | +15.08% |
| 2026 Q1 report | 2026-04-28 | ¥41.99M | -15.21% | -14.57% | +12.20% | 0.21 | 1.71% | -2.68% | -17.10% | -16.48% |
| 2025 annual report | 2026-04-28 | ¥261.61M | +19.28% | +1.13% | +7.76% | 1.31 | 11.16% | -2.68% | -17.10% | -16.48% |
| 2025 Q3 report | 2025-10-31 | ¥196.90M | +12.80% | -9.85% | +9.52% | 0.99 | 8.46% | -0.46% | -12.11% | -7.42% |
| 2025 interim report | 2025-08-30 | ¥149.32M | +22.38% | -10.64% | +4.90% | 0.75 | 6.44% | +12.82% | -14.27% | -15.12% |
| 2025 Q1 report | 2025-04-15 | ¥49.53M | -5.68% | -4.78% | +3.90% | 0.25 | 2.18% | -5.91% | +11.44% | +8.43% |
| 2024 annual report | 2025-04-15 | ¥219.33M | +0.11% | +2.85% | +4.14% | 1.13 | 10.51% | -5.91% | +11.44% | +8.43% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.